X
Record #70461

Targeted immunotherapy for HER2-low breast cancer with 17p loss

Original paper date
Feb 10, 2021
Institution
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA · Heidelberg Pharma Research GmbH, Ladenburg 68526, Germany · Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USA · Departments of Surgery and Urology, Immunobiology and Transplant Science Center, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA · Department of Medicine, Weill Cornell Medicine of Cornell University, New York, NY 10065, USA · Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA · Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA · Indiana University Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Toxicology
Notes from Retraction Watch

see also: https://pubpeer.com/publications/D0D97D0392634683B3C1E237C30978

Citation lifecycle

How this paper is being cited

Pre-retraction
25
Same day
0
Post-retraction
0
% post-retraction
0.0%
~4.8 citations/yr before retraction
— citing papers

Who is still citing this work

Loading…
Back to browse